PDE, Phosphodiesterase
The Dunce cAMP Phosphodiesterase PDE-4 Negatively Regulates Gαs-Dependent and Gαs-Independent cAMP Pools in the Caenorhabditis elegans Synaptic Signaling Network
20
“Ameliorative Effects of Phosphodiesterase (PDE) Inhibitors in Potassium Dichromate-Induced Acute Renal Failure in Rats” by Abeer A. A. Salama, Rasha E. Mostafa, Enayat A. Omara, Egypt.
7
Rieder, Florian (2004): Wirkung der spezifischen Phosphodiesterase-Inhibitoren Roflumilast und Pumafentrine im Mausmodell der Dextran-Sodium-Sulfat-induzierten Kolitis. Dissertation, LMU München: Medizinische Fakultät
121
Role of adenylate cyclase, guanylate cyclase enzyme and phosphodiesterase isozyme modulation in animal models of epilepsy.
33
Inhibitors of cyclic nucleotide phosphodiesterase isozymes type III and type IV suppress mitogenesis of rat mesangial cells
11
International Journal of Scientific Research and Modern Education (IJSRME) ISSN (Online): 2455 – 5630 www.rdmodernresearch.com) Volume I, Issue I, 2016
9
Murine AKAP7 Has a 2′,5′ Phosphodiesterase Domain That Can Complement an Inactive Murine Coronavirus ns2 Gene
11
Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV
10
Synthesis, Anticancer, Anti Tumor, Anti Diabetic and Anti Asthmatic Screening of Some Novel Clubbed Tetrazole Moiety Compounds
9
Phosphodiesitrase activity of some Egyptian snake venoms: biochemical and immunological characteristics and effect on blood coagulation of phosphodiesterase enzyme from Naja nigricollis venom
11
Ocimum gratissimum Linn Leaves reduce the key enzymes activities relevant to erectile dysfunction in isolated penile and testicular tissues of rats
10
Cardiovascular Disease Risk Assessment and Treatment of Erectile Dysfunction in Men with Diabetes Mellitus
7
Structural studies on substrate and inhibitor selectivity of phosphodiesterases
109
Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy.
11
Advanced Mobiflage for PDE Enabled Storage
8
Sequential Programming for PDE Constrained Optimizations
124
Construction Solutions of PDE in Parametric Form
17
True Navier–Stokes Vector PDE
5
Limit of the Solution of a PDE in the Degenerate Case
5
Particles and biomembranes : a variational PDE approach
185